H. Lundbeck A/S (CPH:HLUN.B)
Denmark flag Denmark · Delayed Price · Currency is DKK
38.42
+2.48 (6.90%)
May 23, 2025, 1:40 PM CET

H. Lundbeck Company Description

H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.

It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products.

The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals.

It has a partnership collaboration with Otsuka Pharmaceuticals Co., Ltd.; and collaboration with FeetMe focusing on the use of sensor shoe soles.

H. Lundbeck A/S also has a collaboration with Alloy Therapeutics, Inc. for the discovery of novel biologics therapies.

The company was founded in 1915 and is headquartered in Valby, Denmark.

H. Lundbeck A/S
H. Lundbeck logo
Country Denmark
Founded 1915
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 5,707
CEO Charl van Zyl

Contact Details

Address:
Ottiliavej 9
Valby
Denmark
Phone 45 36 30 13 11

Stock Details

Ticker Symbol HLUN.B
Exchange Copenhagen Stock Exchange
Fiscal Year January - December
Reporting Currency DKK
ISIN Number DK0061804770
SIC Code 2834

Key Executives

Name Position
Charl van Zyl President and Chief Executive Officer
Joerg Hornstein Chief Financial Officer and Executive Vice President of Corporate Functions
Lars Bang Executive Vice President of Product Development and Supply
Dr. Per Johan Luthman Ph.D. Executive Vice President of Research and Development
Dr. Tarek Samad Ph.D. Senior Vice President and Head of Research
Jens Hoyer Vice President and Head of Investor Relations
Tine Ostergaard Hansen Senior Vice President of Corporate Communications and Public Affairs
Dianne Holto Executive Vice President of People and Culture
Palle Holm Olesen Chief Specialist and Vice President of Investor Relations
Bjorn R. Mogensen Senior Vice President of Group Finance